Deaths related to the use of prescription opioids

CMAJ. Canadian Medical Association Journal

Volumn 181, Issue 12, 2009, Pages 881-882

  Fischer, Benedikt ^a,b   Rehm, Jürgen ^b,c,d  

^a SIMON FRASER UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CODEINE; FENTANYL; HYDROCODONE; METHADONE; OPIATE; OXYCODONE;

CANADA; CHRONIC PAIN; DEATH; DRUG FATALITY; DRUG USE; HEALTH CARE POLICY; HUMAN; MORBIDITY; MORTALITY; NOTE; OUTCOME ASSESSMENT; PRESCRIPTION; PUBLIC HEALTH;

EID: 73249119113     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.091791     Document Type: Note

References (10)

1. Dhalla IA, Mamdani MM, Sivilotte MLA, et al. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009. DOI:10.1503/cmaj.090784.
2. Fischer B, Rehm J, Goldman B, et al. Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health 2008;99:182-4.
3. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). J Anal Toxicol 2006;30:603-10.
4. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27.
5. DeBeck K, Wood E, Montaner J, et al. Canada's 2003 renewed drug strategy - an evidence-based review. Toronto (ON): HIV/AIDS Policy Law Rev 2006;(2/3):1-12. Available: www.aidslaw.ca/publications/interfaces/downloadFile. php?ref=957 (accessed 2009 Oct. 26).
6. Novak S, Nemeth WC, Lawson KA. Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med 2004;5:59-65.
7. International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2004 (Statistics for 2002). New York (NY): 2004; United Nations.
8. Fischer B, Gittens J, Rehm J. Characterizing the "awakening elephant" of prescription opioid misuse in North America: epidemiology, harms, interventions. Contemp Drug Probl 2008;35:397-426.
9. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007;105:205-21.
10. Brushwood DB. Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics 2003;31:41-54.